The provided information describes a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $28,188.67, is a delivery order for 4,566,709,279 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a firm fixed-price pricing type and an ultimate completion date of December 13, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) and plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Generated 3/13/25, 10:00 AM